Search Results - Laing, Shiona M.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review

    Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospect... by Abell, Jill E., Laing, Shiona M., Barker, Tara C., Norry, Elliott C., Starzyk, Kathryn, Goodman, Shaun G., Dellborg, Mikael, Steg, P. Gabriel, Giugliano, Robert P.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase 3 study of migalastat HCl for Fabry disease: Stage 1 results

    Phase 3 study of migalastat HCl for Fabry disease: Stage 1 results by Nicholls, Kathy, Germain, Dominique P., Feliciani, Claudio, Shankar, Suma, Ezgu, Fatih, Janmohamed, Salim G., Laing, Shiona M., Schroyer, Rosemary O., Bragat, Alex C., Sitaraman, Sheela, Boudes, Pol F.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent

    Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent by Leach, Colin A, Brown, Thomas H, Ife, Robert J, Keeling, David J, Laing, Shiona M, Parsons, Michael E, Price, Carolyn A, Wiggall, Kenneth J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogs of 4-(arylamino)quinolines

    Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogs of 4-(arylamino)quinolines by Brown, Thomas H, Ife, Robert J, Keeling, David J, Laing, Shiona M, Leach, Colin A, Parsons, Michael E, Price, Carolyn A, Reavill, David R, Wiggall, Kenneth J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial

    Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial by Steg, Philippe Gabriel, Jolly, Sanjit S, Mehta, Shamir R, Afzal, Rizwan, Xavier, Denis, Rupprecht, Hans-Jurgen, López-Sendón, Jose L, Budaj, Andrzej, Diaz, Rafael, Avezum, Alvaro, Widimsky, Petr, Rao, Sunil V, Chrolavicius, Susan, Meeks, Brandi, Joyner, Campbell, Pogue, Janice, Yusuf, Salim

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux

    Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during perc... by Steg, Philippe Gabriel, MD, Mehta, Shamir, MD, MSc, Jolly, Sanjit, MD, Xavier, Denis, MD, Rupprecht, Hans-Juergen, MD, Lopez-Sendon, Jose Luis, MD, Chrolavicius, Susan, BScN, Rao, Sunil V., MD, Granger, Christopher B., MD, Pogue, Janice, MSc, MA, Laing, Shiona, BSc, Yusuf, Salim, FRS(C), DPhil

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: